IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q2 2024 Holdings

Filed 2024-08-14 | 74 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Viatris Inc(VTRS)COM92556V106$14.1M1,329,2821.0%
Humana Inc(HUM)COM444859102$14.2M38,0231.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$14.9M34,5931.0%
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$16.8M30,8001.1%
Protagonist Therapeutics Inc(PTGX)COM74366E102$17.5M505,8361.2%
ELI Lilly & Co(LLY)COM532457108$19.2M21,2331.3%
Novo-Nordisk A S(NVO)ADR670100205$21.0M146,9561.4%
Ionis Pharmaceuticals Inc(IONS)COM462222100$21.8M456,8811.5%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$23.4M633,0151.6%
Repligen Corp(RGEN)COM759916109$24.5M194,2911.7%
Community Health SYS Inc New(CYH)COM203668108$27.0M8,037,4701.8%
Healthequity Inc(HQY)COM42226A107$35.6M413,5312.4%
Bio-Techne Corp(TECH)COM09073M104$38.9M543,0442.7%
HCA Healthcare Inc(HCA)COM40412C101$43.5M135,4803.0%
Revvity Inc(RVTY)COM714046109$47.4M451,5823.2%
Inspire MED SYS Inc(INSP)COM457730109$71.3M533,0114.9%
Vera Therapeutics Inc(VERA)CL A92337R101$73.9M2,043,2145.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$74.2M3,613,6315.1%
United Therapeutics Corp del(UTHR)COM91307C102$75.0M235,3515.1%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$76.7M4,720,4605.3%
Insmed Inc(INSM)COM PAR $.01457669307$77.4M1,155,5885.3%
Natera Inc(NTRA)COM632307104$127.1M1,173,4948.7%
GSK PLC(GSK)SPONSORED ADR37733W204$133.5M3,468,0809.1%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$136.8M285,6009.4%
PreviousPage 2 of 2